Theriva Biologics TOVX
NYSE TOVX
$0.24 +0.01 (+4.35%)
At close: Aug 20, 2026 · 4:00 PM EDT

Theriva Biologics (TOVX) Loans - Net (2013)

Theriva Biologics (TOVX) posted quarterly Loans - Net of $700000.0 for Q2 2013, little changed quarter-over-quarter from $700000.0 in Q1 2013.

Theriva Biologics (TOVX) Loans - Net (2013) Analysis & Trends

Theriva Biologics (TOVX) has reported Loans - Net for 1 consecutive years, with $700000.0 the latest figure, recorded in Q2 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Loans - Net (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -
10 Theriva Biologics 10.90 Mn 10.90 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2013 700,000.00
Jun 30, 2013 700,000.00
Mar 31, 2013 700,000.00
Mar 31, 2013 700,000.00